These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21504332)

  • 1. Future acceptance of an artificial pancreas in adults with type 1 diabetes.
    van Bon AC; Brouwer TB; von Basum G; Hoekstra JB; DeVries JH
    Diabetes Technol Ther; 2011 Jul; 13(7):731-6. PubMed ID: 21504332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perception and future acceptance of an artificial pancreas.
    van Bon AC; Kohinor MJ; Hoekstra JB; von Basum G; deVries JH
    J Diabetes Sci Technol; 2010 May; 4(3):596-602. PubMed ID: 20513325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit.
    Cemeroglu AP; Stone R; Kleis L; Racine MS; Postellon DC; Wood MA
    Pediatr Diabetes; 2010 May; 11(3):182-7. PubMed ID: 19958460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.
    Oron T; Farfel A; Muller I; Miller S; Atlas E; Nimri R; Phillip M
    Diabetes Technol Ther; 2014 Nov; 16(11):699-705. PubMed ID: 25211216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology.
    Bevier WC; Fuller SM; Fuller RP; Rubin RR; Dassau E; Doyle FJ; Jovanovič L; Zisser HC
    Diabetes Technol Ther; 2014 Sep; 16(9):590-5. PubMed ID: 24811147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
    J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey.
    Taleb N; Quintal A; Rakheja R; Messier V; Legault L; Racine E; Rabasa-Lhoret R
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):658-665. PubMed ID: 33358714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference for insulin delivery systems among current insulin users and nonusers.
    Summers KH; Szeinbach SL; Lenox SM
    Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of the Artificial Pancreas: Comparing the Effect of Technology Readiness, Product Characteristics, and Social Influence Between Invited and Self-Selected Respondents.
    Oukes T; Blauw H; van Bon AC; DeVries JH; von Raesfeld AM
    J Diabetes Sci Technol; 2019 Sep; 13(5):899-909. PubMed ID: 30646756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).
    Ziegler C; Liberman A; Nimri R; Muller I; Klemenčič S; Bratina N; Bläsig S; Remus K; Phillip M; Battelino T; Kordonouri O; Danne T; Lange K
    J Diabetes Res; 2015; 2015():590308. PubMed ID: 26581230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
    Patton SR; Dolan LM; Henry R; Powers SW
    Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.